Original Research
Published on 22 Oct 2024
Ustekinumab affects myofibroblast metabolism to alleviate intestinal fibrosis by targeting KDELC1 in Crohn’s disease through multi-machine learning combined with single-cell sequencing analysis
in Gastroenterology
- 559 views